Logo image of AKAST.OL

AKASTOR ASA (AKAST.OL) Stock Fundamental Analysis

Europe - OSL:AKAST - NO0010215684 - Common Stock

11.38 NOK
0 (0%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AKAST. AKAST was compared to 40 industry peers in the Energy Equipment & Services industry. While AKAST seems to be doing ok healthwise, there are quite some concerns on its profitability. AKAST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AKAST had negative earnings in the past year.
In the past year AKAST has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AKAST reported negative net income in multiple years.
In multiple years AKAST reported negative operating cash flow during the last 5 years.
AKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFAKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

With a Return On Assets value of -0.93%, AKAST is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
AKAST's Return On Equity of -1.06% is on the low side compared to the rest of the industry. AKAST is outperformed by 82.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.25%, AKAST is doing worse than 85.00% of the companies in the same industry.
Industry RankSector Rank
ROA -0.93%
ROE -1.06%
ROIC 0.25%
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
AKAST.OL Yearly ROA, ROE, ROICAKAST.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

In the last couple of years the Profit Margin of AKAST has grown nicely.
The Operating Margin of AKAST (5.52%) is worse than 80.00% of its industry peers.
AKAST has a Gross Margin of 27.91%. This is in the better half of the industry: AKAST outperforms 62.50% of its industry peers.
AKAST's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.52%
PM (TTM) N/A
GM 27.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y77.83%
PM growth 5Y213.61%
GM growth 3Y-21.44%
GM growth 5Y-8.67%
AKAST.OL Yearly Profit, Operating, Gross MarginsAKAST.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

5

2. Health

2.1 Basic Checks

AKAST has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AKAST remains at a similar level compared to 1 year ago.
The number of shares outstanding for AKAST has been increased compared to 5 years ago.
The debt/assets ratio for AKAST has been reduced compared to a year ago.
AKAST.OL Yearly Shares OutstandingAKAST.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AKAST.OL Yearly Total Debt VS Total AssetsAKAST.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

AKAST has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
AKAST has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. AKAST outperforms 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.02
WACC10.34%
AKAST.OL Yearly LT Debt VS Equity VS FCFAKAST.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.19 indicates that AKAST has no problem at all paying its short term obligations.
AKAST has a better Current ratio (2.19) than 77.50% of its industry peers.
A Quick Ratio of 2.19 indicates that AKAST has no problem at all paying its short term obligations.
AKAST's Quick ratio of 2.19 is fine compared to the rest of the industry. AKAST outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.19
AKAST.OL Yearly Current Assets VS Current LiabilitesAKAST.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1

3. Growth

3.1 Past

AKAST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.78%.
Measured over the past years, AKAST shows a very strong growth in Earnings Per Share. The EPS has been growing by 75.95% on average per year.
AKAST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -61.04%.
The Revenue for AKAST have been decreasing by -44.12% on average. This is quite bad
EPS 1Y (TTM)-104.78%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%-102.33%
Revenue 1Y (TTM)-61.04%
Revenue growth 3Y-31.61%
Revenue growth 5Y-44.12%
Sales Q2Q%-13.19%

3.2 Future

The Earnings Per Share is expected to decrease by -38.02% on average over the next years. This is quite bad
The Revenue is expected to decrease by -22.85% on average over the next years. This is quite bad
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3Y-38.02%
EPS Next 5YN/A
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3Y-22.85%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKAST.OL Yearly Revenue VS EstimatesAKAST.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
AKAST.OL Yearly EPS VS EstimatesAKAST.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKAST. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 22.10, the valuation of AKAST can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AKAST indicates a rather expensive valuation: AKAST more expensive than 82.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, AKAST is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 22.1
AKAST.OL Price Earnings VS Forward Price EarningsAKAST.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKAST is valued expensively inside the industry as 82.50% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.68
AKAST.OL Per share dataAKAST.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as AKAST's earnings are expected to decrease with -38.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.2%
EPS Next 3Y-38.02%

0

5. Dividend

5.1 Amount

AKAST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKASTOR ASA

OSL:AKAST (10/3/2025, 7:00:00 PM)

11.38

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-10 2025-07-10
Earnings (Next)10-30 2025-10-30
Inst Owners17.33%
Inst Owner ChangeN/A
Ins Owners1.64%
Ins Owner ChangeN/A
Market Cap3.12B
Analysts86
Price Target20.4 (79.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.61%
Min Revenue beat(2)-13.82%
Max Revenue beat(2)-5.4%
Revenue beat(4)2
Avg Revenue beat(4)-2.08%
Min Revenue beat(4)-13.82%
Max Revenue beat(4)10.48%
Revenue beat(8)4
Avg Revenue beat(8)-3.02%
Revenue beat(12)5
Avg Revenue beat(12)-15.39%
Revenue beat(16)9
Avg Revenue beat(16)-8.29%
PT rev (1m)0%
PT rev (3m)-4.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.1
P/S 9.06
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA 46.68
EPS(TTM)-0.22
EYN/A
EPS(NY)0.52
Fwd EY4.53%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.26
BVpS19.95
TBVpS19.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.93%
ROE -1.06%
ROCE 0.32%
ROIC 0.25%
ROICexc 0.26%
ROICexgc 0.26%
OM 5.52%
PM (TTM) N/A
GM 27.91%
FCFM N/A
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y77.83%
PM growth 5Y213.61%
GM growth 3Y-21.44%
GM growth 5Y-8.67%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 3.95
Cap/Depr 92.5%
Cap/Sales 10.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 2.19
Altman-Z N/A
F-Score4
WACC10.34%
ROIC/WACC0.02
Cap/Depr(3y)202.64%
Cap/Depr(5y)136.86%
Cap/Sales(3y)20%
Cap/Sales(5y)16.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.78%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%-102.33%
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3Y-38.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-61.04%
Revenue growth 3Y-31.61%
Revenue growth 5Y-44.12%
Sales Q2Q%-13.19%
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3Y-22.85%
Revenue Next 5YN/A
EBIT growth 1Y-96.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-92.76%
EBIT Next 3Y-54.03%
EBIT Next 5YN/A
FCF growth 1Y59.87%
FCF growth 3YN/A
FCF growth 5Y42.34%
OCF growth 1Y83.89%
OCF growth 3YN/A
OCF growth 5Y34.38%